Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
<p>Abstract</p> <p>Background</p> <p>Two recombinant, live attenuated human parainfluenza virus type 1 (rHPIV1) mutant viruses have been developed, using a reverse genetics system, for evaluation as potential intranasal vaccine candidates. These rHPIV1 vaccine candidate...
Main Authors: | Skiadopoulos Mario H, Collins Peter L, Surman Sonja R, Castaño Adam, Bartlett Emmalene J, Murphy Brian R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/4/1/67 |
Similar Items
-
Human Parainfluenza Virus (HPIV) Detection in Hospitalized Children with Acute Respiratory Tract Infection in the Western Cape, South Africa during 2014–2022 Reveals a Shift in Dominance of HPIV 3 and 4 Infections
by: Jane Parsons, et al.
Published: (2023-08-01) -
Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
by: Pytel, K, et al.
Published: (2016) -
Human Parainfluenza Virus Type 3 Matrix Protein Reduces Viral RNA Synthesis of HPIV3 by Regulating Inclusion Body Formation
by: Shengwei Zhang, et al.
Published: (2018-03-01) -
Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion
by: Konttinen Yrjö T, et al.
Published: (2009-03-01) -
The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome.
by: Henrick Schomacker, et al.
Published: (2012-01-01)